[1]王 霞,甘琴霞△,李 娟.益气化瘀盆炎汤加减治疗盆腔炎气虚血瘀证疗效及对患者血液微循环的影响*[J].陕西中医,2020,(12):1722-1726.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.011]
　WANG Xia,GAN Qinxia,LI Juan..Effect of modified Yiqi Huayu Penyan decoction on treatment of pelvic inflammation of Qixu Xueyu syndrome and its influence on blood microcirculation[J].,2020,(12):1722-1726.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.011]
点击复制

益气化瘀盆炎汤加减治疗盆腔炎气虚血瘀证疗效及对患者血液微循环的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年12期
页码:
1722-1726
栏目:
临床研究
出版日期:
2020-12-05

文章信息/Info

Title:
Effect of modified Yiqi Huayu Penyan decoction on treatment of pelvic inflammation of Qixu Xueyu syndrome and its influence on blood microcirculation
作者:
王 霞1; 甘琴霞1△; 李 娟2
1.江苏省第二中医院(南京 210019); 2.南京医科大学附属妇产科医院(南京 210009)
Author(s):
WANG Xia; GAN Qinxia; LI Juan.
Jiangsu Second Hospital of Traditional Chinese Medicine(Nanjing 210019)
关键词:
益气化瘀盆炎汤;  血液微循环;  盆腔炎;  免疫功能;  炎症因子;  气虚血瘀证
Keywords:
Yiqi Huayu Penyan decoction;  Blood microcirculation;  Pelvic inflammatory;  Immune function;  Inflammatory factor;  Qixu Xueyu syndrome
分类号:
R711.33
DOI:
DOI:10.3969/j.issn.1000-7369.2020.12.011
文献标志码:
A
摘要:
目的:探讨益气化瘀盆炎汤加减治疗盆腔炎气虚血瘀证临床疗效及对患者血液微循环的影响。方法:将96例盆腔炎气虚血瘀证患者,随机分为对照组与观察组,各48例。对照组给予左氧氟沙星联合桂枝茯苓胶囊治疗,观察组在对照组治疗基础上给予益气化瘀盆炎汤加减治疗,连续用药2个疗程。比较两组患者临床疗效、治疗前后的中医症候积分、炎性包块直径、盆腔积液深度、血液微循环指标、炎症因子水平、补体C3和C4水平,及用药期间的不良反应发生情况。结果:观察组临床治愈率较对照组更高,组间比较差异均有统计学意义(P<0.05)。观察组治疗后的中医症候积分、炎性包块直径、盆腔积液深度均较对照组下降更显著,观察组治疗后的血清ICAM-1、D-二聚体、血浆黏度、红细胞沉降率、血小板聚集率水平均较对照组下降显著,IL-2、IL-10、MMP-2水平均较对照组明显提高,组间比较差异均有统计学意义(P<0.05)。观察组治疗后的补体C3和C4水平均较对照组高,组间比较差异具有统计学意义(P<0.05)。两组用药过程中均未见肝肾功能损伤等严重不良反应发生。结论:益气化瘀盆炎汤加减治疗盆腔炎气虚血瘀证疗效较好,其机制可能与改善患者血液微循环、免疫功能及控制炎症因子水平有关。
Abstract:
Objective:To explore the clinical effect of Yiqi Huayu Penyan decoction in treatment of pelvic inflammatory disease with Qixu Xueyu syndrome and its influence on blood microcirculation of patients.Methods:96 patients with pelvic inflammatory disease with Qixu Xueyu syndrome were randomly divided into control group and observation group,with 48 cases in each.The control group was treated with levofloxacin combined with Guizhi Fuling capsules,and the observation group was treated with Yiqi Huayu Penyan decoction on the basis of the treatment of the control group.The treatment was continued for 2 courses.Statistics of clinical efficacy,TCM syndrome score before and after treatment,sex mass diameter,pelvic effusion depth,blood microcirculation indicators,inflammatory factor levels,complement C3 and C4,and count the occurrence of adverse drug reactions during patients' medication.Results:The clinical cure rate of the observation group was significantly higher than that of the control group,difference between groups statistically significant(P<0.05).The observation group's TCM syndrome score,inflammatory mass diameter,and pelvic effusion depth after treatment were better than those of the control group.Serum ICAM-1,D-dimer,plasma viscosity,erythrocyte sedimentation rate,and platelet aggregation rate of the observation group after treatment were lower than those of the control group,and serum IL-2,IL-10,MMP- 2.The level was higher than that of the control group,difference between groups statistically significant(P<0.05).After treatment,C3 and C4 levels of the observation group were significantly higher than those of the control group,difference between groups statistically significant(P<0.05).There were no serious complications such as liver and kidney function damage in the two groups.Conclusion:Yiqi Huayu Penyan decoction has satisfactory effect in treatment of pelvic inflammatory disease with Qixu Xueyu syndrome,and can significantly improve the clinical efficacy.The mechanism of action may be related to improving the blood microcirculation and immune function,control the levels of inflammatory factor.

参考文献/References:

[1] 贾利平,刘玉珠,周小飞.中西医结合治疗慢性盆腔炎疗效观察及安全性分析[J].中华中医药学刊,2018,36(4):939-941.
[2] 秦伟丽.盆腔炎汤保留灌肠配合小剂量氟罗沙星治疗慢性盆腔炎疗效观察[J].陕西中医,2015,36(3):263-264.
[3] 中华医学会妇产科学分会感染性疾病协作组.盆腔炎症性疾病诊治规范[J].中华妇产科杂志,2019,54(7):433-437.
[4] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:243-258.
[5] 黄发婷,梁 漫,孙志圣.盆腔灌注联合TDP治疗慢性盆腔炎临床疗效研究[J].陕西医学杂志,2019,48(2):205-207.
[6] 戴莺莺.康妇消炎栓联合阿奇霉素治疗支原体感染盆腔炎的疗效分析[J].中华全科医学,2016,14(12):2073-2075.
[7] 张立双,杨丰文,张俊华,等.桂枝茯苓胶囊/丸治疗慢性盆腔炎性疾病临床随机对照试验的系统评价[J].中国中药杂志,2017,42(8):1500-1509.
[8] 张鹏晖.桂枝茯苓胶囊联合磷霉素氨丁三醇对慢性盆腔炎患者血液流变学、细胞炎性介质和免疫功能的影响[J].中国妇幼保健,2018,33(24):5778-5781.
[9] 黄 宇,穆秋红.益气化瘀盆炎汤治疗慢性盆腔炎气虚血瘀证临床观察[J].辽宁中医药大学学报,2013,15(12):139-141.
[10] 黄巧玲.盆腔炎汤剂联合物理疗法对慢性盆腔炎患者炎性反应免疫学和血液流变学指标的影响[J].中医学报,2016,31(5):734-737.
[11] 张艳林.益气化瘀盆炎汤加减联合抗生素对盆腔炎气虚血瘀证患者炎性包块大小及血流变的影响[J].四川中医,2017,35(11):162-164.
[12] 曹晓云,吕 燕.自拟红藤汤保留灌肠联合体外电场热疗治疗慢性盆腔炎合并盆腔积液疗效及对血清D-二聚体、C反应蛋白的影响[J].现代中西医结合杂志,2017,26(23):2555-2558.
[13] 王依静,张碧黎.盆腔炎患者血清Th1/Th2及外周血T淋巴细胞亚群的变化研究[J].中国妇幼保健,2016,31(23):5008-5009.
[14] 张育英,黄梦洁,张润平.替硝唑腹腔灌注与静脉滴注治疗慢性盆腔炎疗效比较[J].陕西医学杂志,2014,43(7):929-930.
[15] 谢鲁寒,高 爽,彭琳洁,等.细菌性阴道病及其合并盆腔炎患者的阴道菌群分析[J].中国微生态学杂志,2019,31(5):588-591,600.
[16] 于红艳,方开英,张瑛瑜,等.盆炎净胶囊联合头孢呋辛钠治疗慢性盆腔炎的临床研究[J].药物评价研究,2020,43(2):304-307.
[17] 张灵利,何艳杰,李 红.幽门螺旋杆菌相关胃病不同中医证候患者胃黏膜MMP-2、TIMP-1的表达及临床意义[J].陕西中医,2020,41(3):353-356.
[18] 汪万英,石建华,承泽农.MMP-2、TIMP-2和NF-κB P65 在甲状腺乳头状癌中的表达及意义[J].中华全科医学,2011,9(2):173-174,206,封3.
[19] 臧志华,李静文,杨晓红,等.桂荔汤治疗寒湿凝滞型慢性盆腔炎临床疗效及对患者生存质量的影响[J].现代中西医结合杂志,2018,27(35):3960-3963.
[20] 杨 兰,杨明末.益气消积汤内服和解毒化癥汤灌肠治疗慢性盆腔炎性包块54例[J].中国实验方剂学杂志,2015,21(10):212-215.
[21] 焦文妤,尚家璐,李树霞.慢性阻塞性肺疾病患者血清补体C1q肿瘤坏死因子相关蛋白5与肺功能及炎症反应相关性研究[J].陕西医学杂志,2019,48(12):1616-1618,1621.
[22] 刘莉萍,宣荣荣,朱 虹,等.硬膜外分娩镇痛对产妇炎症因子、补体及免疫功能的影响分析[J].中华全科医学,2019,17(2):241-244.

备注/Memo

备注/Memo:
*国家自然科学基金资助项目(81603372)
更新日期/Last Update: 2020-12-11